Synthetic biology is an emerging field uniting scientists from all disciplines with the aim of designing or redesigning biological processes. Initially, synthetic biology breakthroughs came from microbiology, chemistry, physics, computer science, materials science, mathematics, and engineering disciplines. A transition to multicellular systems is the next logical step for synthetic biologists and plants will provide an ideal platform for this new phase of research. This meeting report highlights some of the exciting plant synthetic biology projects, and tools and resources, presented and discussed at the 2013 GARNet workshop on plant synthetic biology.
Introduction
Synthetic biology is a new approach in scientific research but, in many ways, it is the natural progression of the way modern science has been undertaken for the past two decades. It is first of all driven by the explorative and inventive nature of fundamental research, and has the potential for enormous commercial impact. Secondly, synthetic biology is inherently inter-disciplinary, cutting across the scientific fields of chemistry, physics, biology, mathematics, engineering, social science, and computer science, as well as encompassing design, economics, and marketing. These two basic principles of synthetic biology are in keeping both with the current need to maximize returns from public funding, and with the cross-cutting nature of biological research since the dawn of the genomics era.
Synthetic biology hit the UK government's radar in 2012. The Department of Business Innovation and Skills (BIS) instigated a roadmap for UK synthetic biology (UK Synthetic Biology Roadmap Coordination Group, 2012), a £20 million investment commitment in this area, and the Synthetic Biology Leadership Council to assess progress, update recommendations, and shape priorities. In 2013, this investment translated into two opportunities for collaborative synthetic biology projects: the Research Councils UK (RCUK) call for proposals for Multi-disciplinary Research Centres and the ERASynBio call for transnational research projects across Europe and the US; and the UK enabling tools and technologies development fund from the UK government funding bodies: the Technology Strategy Board (TSB), the Biotechnology and Biological Sciences Research Council (BBSRC), and the Engineering and Physical Sciences Research Council (EPSRC). In addition, TSB, BBSRC, and EPSRC awarded £10 million to a new Innovation and Knowledge Centre based at Imperial College London. This Centre was opened in July 2013 to facilitate the transition between synthetic biology research and industrial application.
In this context, GARNet, the Arabidopsis research network, held the second UK workshop on synthetic biology for the plant sciences at the University of Nottingham on 21-22 May 2013. This followed on from the 4th New Phytologist workshop in May 2012 (Osbourn et al., 2012) , which also aimed to introduce synthetic biology to UK plant scientists.
Synthetic biology
The most common definition of synthetic biology is the design and construction of new biological parts, devices, and systems and the re-design of existing biological systems (Arkin et al., 2009) . For many biologists, this means reprogramming systems from the DNA level up, whilst for other groups, including the UK's Synthetic Biology Leadership Council, it must also include a commercial end-point (Arkin et al., 2009) . From GARNet's perspective, it is key that fundamental research underpins all of synthetic biology and that innovative products are a consequence of this.
At a time when Western economies are struggling, synthetic biology is viewed as a potential game-changer for innovation and industry. As a result, many synthetic biology funders worldwide closely monitor the bioethics of synthetic biology research and application. The USA and the European Commission both have ethical and best practice guidelines that must be considered when drafting proposals and strictly adhered to throughout the project (The National Science Federation, 2012; The European Group on Ethics in Science and New Technologies to the European Commission, 2009).
As showcased at the GARNet workshop, projects within the sphere of 'synthetic biology' vary greatly in scope. They start at the molecular scale, for example, the elegant de novo protein construction kit of coiled-coil peptides (Moutevelis and Woolfson, 2009; Fletcher et al., 2012) that can be used to make a growing number of structures including self-assembling cages (Fletcher et al., 2013) . At the supramolecular levels, DNA and the design and generation of minimal synthetic genomes are important goals in synthetic biology. The ambitious Yeast 2.0 project aims to answer some of the fundamental questions underlying genomics, such as the role of introns and the importance of genome organization (Dymond et al., 2011) , and to provide a predictable host cell for future synthetic biologists.
Methods developed by synthetic biology, in particular cloning and genome editing techniques, have expanded the possibilities of traditional genetic and metabolic engineering (Neumann and Neumann-Staubitz, 2010) . The production of high value products of complexities not previously possible is now a reality. Artemisinin is an anti-malarial that naturally occurs in the plant Artemisia annua but, until this year, has been unsuitable for mass production. However, the biosynthetic pathway of its precursor artemisinic acid has been re-constructed in Saccharomyces cerevisiae and is now close to being marketed (Paddon et al., 2013) . Further, as described below, nitrogen-fixing wheat is a probable goal rather than an unattainable dream.
Plant synthetic biology
Synthetic biology is likely to be a valuable approach in the plant biologist's toolbox to help meet the challenge of providing food, energy, and other materials from limited natural resources. Plant synthetic biology is key to this application. It is also the next logical step in the progression of synthetic biology after the molecule, genome, and isolated cell level approaches that have been trialled to date: a transition to multicellular systems. As highlighted by workshop attendees in the discussion groups, plants are the obvious choice for this 'next chapter' of synthetic biology. Plant synthetic biologists have an excellent knowledge base to work with, and their subjects are sessile, self-repairing, and not surrounded by the same ethical issues that are often encountered in animal research.
One plant synthetic biology project that exemplifies the potential of plants as platforms for synthetic biology is the nitrogen-fixing cereals project led by Giles Oldroyd at the John Innes Centre. Nitrogen is a critical limiting element for plant growth and development, but use of nitrogen fertilizers is expensive and can have negative environmental impacts.
Oldroyd and colleagues have previously characterized the pathways that allow some plants, such as legumes, to fix their nitrogen via a symbiotic relationship with rhizobium bacteria (Capoen et al., 2011; Oldroyd et al., 2011; Xie et al., 2012) . They are now attempting to synthesize these pathways in wheat to develop a 'self-fertilizing' cereal.
An example of a successfully executed synthetic pathway in plants is the signal transduction system built by June Medford and her group at Colorado State University. The 'sentinel' plant containing the complete synthetic pathway acts as a biosensor that de-colours when it detects a specific molecule(s) such as TNT. Development of this sentinel involved synthesizing and optimizing a bacterial-based signal transduction pathway in plant cells. Importantly, use of a prokaryotic mechanism has generated a synthetic pathway that is isolated from any endogenous activity, minimizing cross-talk within the plant cellular environment and maximizing signal detection (Antunes et al., 2006 (Antunes et al., , 2009 (Antunes et al., , 2011 ).
The two projects described above fit what might be considered goal-oriented synthetic biology: specifically redesigning a plant/crop for a particular aim. Other plant scientists are considering the bigger picture: exploring and quantifying certain aspects of plants to provide tools and resources for the wider plant science community to undertake synthetic biology.
One potential orthogonal 'toolkit' for plant synthetic biology may come from recently identified operon-like clusters (Field et al., 2011; Mugford et al., 2013) . In bacteria, novel antibiotics have been biosynthesized by identification, characterization and rearrangement of gene clusters (Gottelt et al., 2010; Gomez-Escribano et al., 2012) . The discovery that some plant secondary metabolite genes, such as antimicrobial terpenoids in oat and triterpenes in the legume Lotus japonicus, are encoded by gene clusters (Krokida et al., 2013; Mugford et al., 2013) presents the possibility of shuffling genes within a cluster to generate novel compounds in plants in the same way as in bacteria.
Despite the advantages of plant models for synthetic biology and their potential uses as outlined above, it remains a fact that plants are more complicated than existing synthetic biology models like Saccharomyces cerevisiae. They have complex signalling pathways, many organs, and often have very large genomes. To try and overcome these limitations and push the boundaries of synthetic biology in plants, workshop speaker Jim Haseloff and a group of international collaborators propose the liverwort Marchantia polymorpha as a new model for plant synthetic biology, due to its streamlined genome architecture (Ohyama et al., 2009) containing less genetic redundancy (Sasaki et al., 2007) than Arabidopsis thaliana, its developmental simplicity and easy cultivation in suspension, agar or on soil. If 'explorative' plant synthetic biology is to become an established field in the UK, adoption of new systems like Marchantia may be necessary.
Tools for synthetic biology in plants
To flourish, plant synthetic biology will need a suite of associated tools and resources, some of which will be plant-specific, but the majority are likely to be adapted from other fields. In fact, one of the underlying principles of synthetic biology is that a biological 'part' should be able to fit into any system and behave in a predictable way. Although building a plant or plant pathways from orthogonal parts-a concept often likened to a child's Lego kit-is not currently feasible, tools that can generate synthetic 'parts' in plants do exist and a few examples are outlined below.
Genome assembly
Gibson Isothermal Assembly, presented at the GARNet workshop by Jim Ajioka (University of Cambridge), is a powerful tool that can be used to assemble several hundred kilobases of DNA into a single molecule. DNA fragments are prepared for assembly by the ligation of specific sequences to each end. In this case, the specific overhangs that frame the DNA fragment are complementary to the overhang of another DNA piece and, during assembly, the DNA pieces fit together like a jigsaw puzzle. As proof of the efficiency and capacity of the method, Gibson et al. (2009) constructed a DNA molecule as large as 583 kb and cloned products up to 300 kb in length in Escherichia coli.
Sylvestre Marillonet's (Leibniz Institute of Plant Biochemistry) Golden Gate modular cloning system (Engler et al., 2008) enables highly efficient assembly of multigene DNA constructs in a single tube using a normal benchtop thermocycler. It is based on Type IIS restriction endonucleases, commonly BsaI, which are targeted to the correct location by BsaI sites that flank the gene or fragment of interest. The enzymes recognize the BsaI sites and make a cut next to them, leaving a specific four base pair overhang on either strand, as shown in Fig. 1A . It is possible for large numbers of different fragments to be generated and ligated in a single cycle; all that is needed is for the BsaI sites to be designed correctly (Fig. 1B) . With proper design, a ligation between two stickyends left from BsaI digestion will result in a 'scarless' clone.
The Modular Cloning (MoClo; Weber et al., 2011) adaptation of Golden Gate is a hierarchical cloning system that enables any multigene construct to be cloned. It is a kit-like method containing a number of modules and vectors to facilitate gene stacking. This eliminates the need for the complex primer design necessary for cloning the BsaI sites and specific flanking sequences on to every DNA part in preparation for assembly. A second adaptation, GoldenBraid (SarrionPerdigones et al., 2011) , simplifies the method still further by using only four destination plasmids. This limits the number of parts it is possible to assemble in one run, but as each destination plasmid has two different Type IIS restriction sites, they can be re-arranged multiple times (Sarrion-Perdigones et al., 2011).
Gibson Assembly and the Golden Gate cloning methods, along with new, fast DNA synthesis platforms, have revolutionized molecular biology, which had previously been limited by restriction enzymes and ligases demanding specificity. Five years ago, building an entire synthetic biology pathway would have been considered impossible due to the time scales involved, but now it is a feasible option.
Genome editing tools
Transcription activator-like effectors (TALEs; and the related TALE-nucleases), presented at the workshop by coinventor Sebastian Schornack, and clustered regularly interspaced short palindromic repeats (CRISPR) technologies are genome editing tools developed for and by synthetic biologists. They perform site-specific, double-stranded DNA cleavage to knock out genes, leaving no foreign DNA behind, and can stimulate homologous recombination or non-homologous end joining.
TALEs are used by some species of the pathogenic proteobacteria genus Xanthomonas to turn on specific host genes (Schornack et al., 2008) . They comprise nuclear localization signals, a transcriptional activation domain, and a series of tandem repeats. Two variable residues in each repeat determine the specific DNA sequence the TALE will target (Boch et al., 2009) . TALE nucleases (TALENs) are TALEs fused to the catalytic domain of a fokI nuclease (Christian et al., 2010) . They cut DNA strands at highly specific locations and can perform deletions ( Fig. 2A) or, if a donor template is provided, trigger seamless insertion by homologous recombination. In 2012, TALEN technology was used to remove a section of a TALE binding site in a rice sucrose efflux transporter hijacked by X. oryzae during infection. This subtle genetic modification, which introduced no foreign DNA at all, rendered rice plants resistant to X. oryzae (Li et al., 2012) .
CRISPR/Cas systems naturally occur in bacteria and archaea, providing defence memory against invading phages: CRISPR-associated endonuclease Cas9 is guided to target genomic sequences, usually key infection genes, by two RNA molecules. In programmable CRISPR/Cas genome editing BsaI as an example. Uni-directional BsaI sites are designed next to specific sequences, S1 and S2. After digestion, the overhangs are complementary to one another and the BsaI sites are excised. When the parts are ligated together, there is no scar. There is no limit to the amount of specific sequences used to top and tail the 'parts,' so this method can be used to build constructs with many parts, as in (B), if the BsaI sites are designed correctly.
technology, specific sequences on a CRISPR RNA molecule are designed to target a specific location on the genome (Jinek et al., 2012; Fig. 2B) . Application of the CRISPR/Cas system for genome editing was initially illustrated in prokaryotes (Gasiunas et al., 2012; Jiang et al., 2013) and animal cells (Hwang et al., 2012; Chang et al., 2013; Cong et al., 2013) . Since the GARNet workshop on Synthetic Biology, CRISPR/Cas technology has also been demonstrated in plants Nekrasov et al., 2013; Shan et al., 2013) .
A synthetic biology expression system
A powerful expression system for synthetic biology applications is the CPMV-HT transient expression system developed at the John Innes Centre by George Lomonossoff. The system is itself a feat of synthetic biology engineering: the inventors modified cow-pea mosaic virus (CPMV) RNA-2 to turn it into a non-viral expression vector that delivers as high an expression as viral systems (Sainsbury and Lomonossoff, 2008) . Unlike traditional transformation, which requires a timescale of weeks before the desired protein is expressed in a young plant, extremely high-level expression is seen just five days after infiltration with the vector. This system enables high-level transient expression of foreign proteins in tobacco (Vardakou et al., 2012) and, if it can be applied to other species, may become a useful tool for synthetic biology. For example, researchers have used this approach to produce empty CPMV-like vessels capable of carrying heavy metals or other foreign molecules like medicines, presenting exciting possibilities in drug delivery (Aljabali et al., 2010) .
Synthetic biology resources
As mentioned in several presentations at the GARNet workshop, many synthetic biology techniques including Gibson Assembly, Golden Gate Cloning, and TALE technology, are accessible for academic use; extensively described in papers, websites, and online protocols. The open ethos of the global synthetic biology community may have been seeded, and was certainly strengthened, by the iGEM Foundation and its associated Registry of Parts. iGEM (international Genetically Engineered Machine) started in 2003 as an annual competition for undergraduate students. Teams work on a synthetic biology project and the resulting products or tools are added to the Parts Registry. Entries in subsequent years build on existing work using the continually expanding tools in the iGEM Registry rather than starting from scratch. The competition now has divisions for schools and entrepreneurs as well as undergraduates. Anyone can use the Registry to deposit and request DNA parts including promoters, primers, ribosome binding sites, and protein domains, for the cost of postage. The Registry therefore provides excellent resources to those working in the synthetic biology sphere. In fact, according to a survey of synthetic biologists (Kahl and Endy, 2013 ), iGEM's Registry of Standard Biological Parts is the most widely used synthetic biology repository. Addgene, also accessible to plant scientists, is the third most commonly used. Like the Parts Registry it is community-based, but small processing fees ensure the quality and reliability of its parts.
As well as the resources equipping the synthetic biology community with physical biological parts, there are many websites providing open source software. One example is the Infobiotics Workbench, the co-creator of which Natalio Krasnagor presented at the GARNet conference; a framework for designing, implementing, and analysing in silico experiments, including model checking (Blakes et al., 2011) .
Software engineers are also building programs for specific synthetic biology applications. Information extracted from time-lapse images of Coleochaete scutata cells was used to build CellModeller, a tool to model cell division in plant tissues and bacterial colonies (Dupuy et al., 2010) . Alongside practical experiments, it is now being tested as a model for the effect of foreign transcription factors on plant morphogenesis.
In order to standardize the many pieces of software generated for and by synthetic biologists, an international team including Guy-Bart Stan (Imperial College London) developed the synthetic biology open language (SBOL). SBOL is an open-source standard for in silico representation of genetic designs-not a programming language and not language-specific, but a graphical representation of a design.
Conclusions
Synthetic biology is an established approach in scientific research, particularly in the microbial and chemical fields. There are notable flagship plant-based synthetic biology projects and, as the existing tools and resources from other spheres are either directly applied, or adapted for use in plant biology, it is expected that the plant synthetic biology community will grow and exploit the potential of this approach for understanding plant systems and engineering biological solutions.
Like the field of systems biology that went before, it will take time for synthetic biology to become an 'everyday' research approach in plant science. Funding opportunities for researchers to explore and build resources in this area (sandpits), alongside a registry of plant parts and the promotion and generation of standards to enable informal or formal sharing of parts, will all help to build a cohesive plant synthetic biology community.
We would strongly encourage plant scientists to dip their toe into the pool of synthetic biology and take advantage of the increased funding targeted to this area. There are many opportunities to get involved in synthetic biology; for example, UK university teams regularly enter the iGEM competition and have won recognition in the past. This is a proven way of discovering more about the synthetic biology mindset and making valuable connections for future work.
The 'synthetic plants' being designed and built by the workshop speakers and mentioned in this article are just the start: in the future, plant synthetic biologists may achieve greater things even than plant sentinels and mineral-fixing crops. The potential impact of synthetic biology in plants is undeniably huge and should not be ignored.
